These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Correlates of immune protection following cutaneous immunization with an attenuated Burkholderia pseudomallei vaccine. Silva EB; Goodyear A; Sutherland MD; Podnecky NL; Gonzalez-Juarrero M; Schweizer HP; Dow SW Infect Immun; 2013 Dec; 81(12):4626-34. PubMed ID: 24101688 [TBL] [Abstract][Full Text] [Related]
7. LVS Δ Tullius MV; Bowen RA; Back PS; Masleša-Galić S; Nava S; Horwitz MA mBio; 2024 Apr; 15(4):e0018624. PubMed ID: 38511933 [TBL] [Abstract][Full Text] [Related]
8. Identification of an OmpW homologue in Burkholderia pseudomallei, a protective vaccine antigen against melioidosis. Casey WT; Spink N; Cia F; Collins C; Romano M; Berisio R; Bancroft GJ; McClean S Vaccine; 2016 May; 34(23):2616-21. PubMed ID: 27091689 [TBL] [Abstract][Full Text] [Related]
10. Identification of a LolC homologue in Burkholderia pseudomallei, a novel protective antigen for melioidosis. Harland DN; Chu K; Haque A; Nelson M; Walker NJ; Sarkar-Tyson M; Atkins TP; Moore B; Brown KA; Bancroft G; Titball RW; Atkins HS Infect Immun; 2007 Aug; 75(8):4173-80. PubMed ID: 17517877 [TBL] [Abstract][Full Text] [Related]
11. Lipopolysaccharide from Burkholderia thailandensis E264 provides protection in a murine model of melioidosis. Ngugi SA; Ventura VV; Qazi O; Harding SV; Kitto GB; Estes DM; Dell A; Titball RW; Atkins TP; Brown KA; Hitchen PG; Prior JL Vaccine; 2010 Nov; 28(47):7551-5. PubMed ID: 20837078 [TBL] [Abstract][Full Text] [Related]
12. Development of capsular polysaccharide-based glycoconjugates for immunization against melioidosis and glanders. Burtnick MN; Heiss C; Roberts RA; Schweizer HP; Azadi P; Brett PJ Front Cell Infect Microbiol; 2012; 2():108. PubMed ID: 22912938 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of a Petersen H; Nieves W; Russell-Lodrigue K; Roy CJ; Morici LA Procedia Vaccinol; 2014 Jan; 8():38-42. PubMed ID: 25165491 [No Abstract] [Full Text] [Related]
14. Evaluation of lipopolysaccharide and capsular polysaccharide as subunit vaccines against experimental melioidosis. Nelson M; Prior JL; Lever MS; Jones HE; Atkins TP; Titball RW J Med Microbiol; 2004 Dec; 53(Pt 12):1177-1182. PubMed ID: 15585494 [TBL] [Abstract][Full Text] [Related]
15. A Burkholderia pseudomallei Outer Membrane Vesicle Vaccine Provides Cross Protection against Inhalational Glanders in Mice and Non-Human Primates. Baker SM; Davitt CJH; Motyka N; Kikendall NL; Russell-Lodrigue K; Roy CJ; Morici LA Vaccines (Basel); 2017 Dec; 5(4):. PubMed ID: 29232837 [No Abstract] [Full Text] [Related]
17. Immunization with the recombinant Burkholderia pseudomallei outer membrane protein Omp85 induces protective immunity in mice. Su YC; Wan KL; Mohamed R; Nathan S Vaccine; 2010 Jul; 28(31):5005-11. PubMed ID: 20546831 [TBL] [Abstract][Full Text] [Related]
18. Protection against experimental melioidosis following immunisation with a lipopolysaccharide-protein conjugate. Scott AE; Ngugi SA; Laws TR; Corser D; Lonsdale CL; D'Elia RV; Titball RW; Williamson ED; Atkins TP; Prior JL J Immunol Res; 2014; 2014():392170. PubMed ID: 24892035 [TBL] [Abstract][Full Text] [Related]
19. Development of Melioidosis Subunit Vaccines Using an Enzymatically Inactive Burkholderia pseudomallei AhpC. Schmidt LK; Orne CE; Shaffer TL; Wilson SM; Khakhum N; Torres AG; Brett PJ; Burtnick MN Infect Immun; 2022 Aug; 90(8):e0022222. PubMed ID: 35862715 [TBL] [Abstract][Full Text] [Related]
20. Heterologously type IV pilus expressed protein of Burkholderia pseudomallei is immunogenic but fails to induce protective immunity in mice. Sangdee K; Waropastrakul S; Wongratanachewin S; Homchampa P Southeast Asian J Trop Med Public Health; 2011 Sep; 42(5):1190-6. PubMed ID: 22299445 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]